Teleflex Incorporated

The medical device affairs outsourcing market is projected to grow to $6.7 billion by 2028 at a CAGR of 7.1%, driven by increasing demand for medical devices, regulatory approvals, and healthcare expenditure. Key trends include digital health technologies, AI, personalized medicine, and environmental sustainability.

Japan lung cancer market to grow from US$3,328.02 million in 2023 to US$9,376.83 million by 2032, driven by increasing prevalence, advancements in diagnostics, and government support.

The Global Drug Device Combination Products Market is projected to reach USD 174.4 billion in 2024 and USD 389.7 billion by 2033 at a CAGR of 9.3%. The US market is expected to grow from USD 59.1 billion in 2024 to USD 125.6 billion by 2033 at a CAGR of 8.7%. Key drivers include technological advancements and rising chronic diseases. Major players include Medtronic, Abbott Laboratories, and Boston Scientific.